logo

UK News

Share

Myomo Inc. (MYO), a wearable medical robotics company, has signed a nationwide payer agreement with HOMELINK, an expert in orthotic and prosthetic reimbursement.

ukinflation-aug15_19feb20.jpg UK consumer price inflation rose more-than-expected in January, after easing in the previous month, to its highest level in six months, led by higher petrol prices. The consumer price index rose 1.8 percent year-on-year following a 1.3 percent increase in December, preliminary data from the Office for National Statistics showed on Wednesday. Economists had forecast 1.6 percent inflation.

pharma-050517_19feb20.jpg Shares of Rubius Therapeutics Inc. (RUBY) have lost over 57 percent of their value from the yearly high of $20.04, recorded on April 5, 2019, and trade around $8.

marketopen-011519_19feb20.jpg European stocks rose on Wednesday after the number of new coronavirus cases in China fell for a second day running. Markets also remain hopeful that China will cut its benchmark loan prime rate Thursday to offset the economic damage caused by the coronavirus outbreak. In economic releases, official...

stockmarkets-aug17_19feb20.jpg European stocks may open higher on Wednesday after data showed a slight decline in new coronavirus cases. Markets remain hopeful on further stimulus measures from global central banks to mitigate the economic impact of the epidemic. According to the National Health Commission, mainland China had...

pharma-010919_19feb20.jpg Today's Daily Dose brings you news about BioCryst Pharma's upcoming regulatory event, Brickell Biotech clearing legal uncertainty related to its lead asset, Bellerophon's phase IIb data of INOPulse, and progress on Lurbinectedin NDA.

InMode Ltd. (INMD) has reported better-than-expected fourth quarter and full-year 2019 financial results and has provided a rosy outlook for 2020.

uk-unemployment-041217_18feb20.jpg UK employment increased further in the three months to December to set a fresh record, while joblessness remained unchanged, indicating the resilience of the labor market amid the uncertainty surrounding Brexit and the general election. The number of employed rose 180,000 from the previous three...

Millendo Therapeutics Inc. (MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, has two clinical trial catalysts to watch out for this year.

hsbc-feb18.jpg Shares of HSBC Holdings Plc were losing around 6 percent in London trading after the British bank focused on Asia reported sharp drop in fiscal 2019 profit, hurt mainly by a hefty impairment charge, despite revenue growth. Further, the company announced a new cost reduction plan of $4.5 billion, which reportedly will include the slashing of 35,000 jobs. HSBC also plans to suspend share buy-backs.

us-premarket-010219_18feb20.jpg European stocks edged lower on Tuesday, with technology and mining stocks pacing the declines, after Apple Inc became the latest company to warn of trouble from the coronavirus outbreak, saying it would not meet its guidance for March-quarter revenue because of slower iPhone production. Germany's...

scPharmaceuticals Inc. (SCPH), which closed at a new 52-week high of $8.64 in the last trading session of Feb.14, has two late-stage programs with significant market potential.

marketopen-011519_18feb20.jpg European stocks look set to open lower on Tuesday after iPhone maker Apple warned that its quarterly sales would miss forecasts due to production delays caused by the coronavirus outbreak. Asian markets remain mostly lower, with Japanese stocks hitting a two-week low as investors remained concerned...

Mersana Therapeutics Inc. (MRSN), which believes that 2020 has the potential to be a transformational year for it, has gained 36 percent so far this year, based on Feb.14 closing price of $7.80.

Beyond Air Inc. (XAIR) has a couple of clinical trial catalysts up its sleeve, making the stock worth watching in the coming months.

Follow RTT
>